Withdrawal of HL7 Version 3 Standard: Medication; Knowledge-Based Query, Release 1

1a. Project Name Withdrawal of HL7 Version 3 Standard: Medication; Knowledge-Based Query, Release 1 1b. Project ID 1713 1c. Is Your Project an Investigative Project (aka PSS-Lite)? No 1d. Is your Project Artifact being Reaffirmed or proceeding to Normative directly after being either Informative or STU? No 1e. Today's Date 1f. Name of standard being reaffirmed 1g. Project Artifact Information 1h. ISO/IEC Standard to Adopt 1i. Does the standard include excerpted text from one or more ISO, IEC or ISO/IEC standards, but is not an identical or modified adoption? 1j. Unit of Measure 2a. Primary/Sponsor WG Pharmacy 2d. Project Facilitator Melva Peters 2e. Other Interested Parties (and roles) 2f. Modeling Facilitator 2g. Publishing Facilitator 2h. Vocabulary Facilitator 2i. Domain Expert Representative 2j. Business Requirements Analyst 2k. Conformance Facilitator 2l. Other Facilitators 2m. Implementers 3a. Project Scope Withdrawal of HL7 Version 3 Standard: Medication; Knowledge-Based Query, Release 1. Decision made by Pharmacy WG - May 10, 2021. https://confluence.hl7.org/pages/viewpage.action?pageId=111123806 Attachments 3b. Project Need There is no intent to update this specification and Pharmacy is not aware of implementations, therefore voted to withdraw. 3c. Security Risk No 3d. External Drivers 3e. Objectives/Deliverables and Target Dates September 2021 Withdrawal ballot 3f. Common Names / Keywords / Aliases: 3g. Lineage 3h. Project Dependencies 3i. HL7-Managed Project Document Repository URL: https://gforge.hl7.org/gf/project/pharmacysig/scmsvn/?action=browse&path=%2Fpharmacysig%2FMaterial%2FNormative%2FMedication%2520Knowledge%2F 3j. Backwards Compatibility No 3k. Additional Backwards Compatibility Information (if applicable) 3l. Using Current V3 Data Types? N/A 3l. Reason for not using current V3 data types? 3m. External Vocabularies N/A 3n. List of Vocabularies 3o. Earliest prior release and/or version to which the compatibility applies 4a. Products V2 Messages - Clinical 4b. For FHIR IGs and FHIR Profiles, what product version(s) will the profiles apply to? 4c. FHIR Profiles Version 4d. Please define your New Product Definition 4d. Please define your New Product Family 5a. Project Intent Revise current standard 5a. White Paper Type 5a. Is the project adopting/endorsing an externally developed IG? 5a. Externally developed IG is to be (select one) 5a. Specify external organization 5a. Revising Current Standard Info HL7 Version 3 Standard: Medication; Knowledge-Based Query, Release 1 5b. Project Ballot Type Withdrawal 5c. Additional Ballot Info 5d. Joint Copyright No 5e. I understand I must submit a Joint Copyright Letter of Agreement to the TSC in order for the PSS to receive TSC approval. no 6a. External Project Collaboration 6b. Content Already Developed 6c. Content externally developed? 6d. List Developers of Externally Developed Content 6e. Is this a hosted (externally funded) project? 6f. Stakeholders 6f. Other Stakeholders 6g. Vendors 6g. Other Vendors 6h. Providers 6h. Other Providers 6i. Realm Universal 7d. US Realm Approval Date 7a. Management Group(s) to Review PSS 7b. Sponsoring WG Approval Date May 10, 2021 7c. Co-Sponsor Approval Date 7c. Co-Sponsor 2 Approval Date 7c. Co-Sponsor 3 Approval Date 7c. Co-Sponsor 4 Approval Date 7c. Co-Sponsor 5 Approval Date 7c. Co-Sponsor 6 Approval Date 7c. Co-Sponsor 7 Approval Date 7c. Co-Sponsor 8 Approval Date 7c. Co-Sponsor 9 Approval Date 7c. Co-Sponsor 10 Approval Date 7e. CDA MG Approval Date 7f. FMG Approval Date 7g. V2 MG Approval Date 7h. Architecture Review Board Approval Date 7i. Steering Division Approval Date 7j. TSC Approval Date